[The nocebo effect].
D000433:1-Propanol / Q000009:adverse effects; D000082:Acetaminophen / Q000009:adverse effects; D000367:Age Factors; D000928:Antidepressive Agents / Q000009:adverse effects; D001241:Aspirin / Q000009:adverse effects; D003061:Codeine / Q000009:adverse effects; D003863:Depression; D004361:Drug Tolerance; D064420:Drug-Related Side Effects and Adverse Reactions; D004597:Electroshock / Q000009:adverse effects; D005260:Female; D005419:Flavonoids / Q000009:adverse effects; D006801:Humans; D007099:Imipramine / Q000009:adverse effects; D007520:Isocarboxazid / Q000009:adverse effects; D008297:Male; D008784:Methysergide / Q000009:adverse effects; D009020:Morphine / Q000009:adverse effects; D010076:Oxazepam / Q000009:adverse effects; D010293:Pargyline / Q000009:adverse effects; D004364:Pharmaceutical Preparations / Q000008:administration & dosage; D010615:Phenacetin / Q000009:adverse effects; D010624:Phenelzine / Q000009:adverse effects; D010653:Phenylbutazone / Q000009:adverse effects; D010817:Physician-Patient Relations; D010919:Placebos / Q000009:adverse effects*; D012737:Sex Factors
D000928:Antidepressive Agents; D005419:Flavonoids; D004364:Pharmaceutical Preparations; D010919:Placebos; D007520:Isocarboxazid; D000082:Acetaminophen; D010076:Oxazepam; D009020:Morphine; D000433:1-Propanol; D010293:Pargyline; D010615:Phenacetin; D010653:Phenylbutazone; D010624:Phenelzine; D007099:Imipramine; D001241:Aspirin; D003061:Codeine; D008784:Methysergide
L'effet nocebo.